About Sotera Health

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

video Watch Our Mission in Action: Safeguarding Global Health®

News Releases

04 Aug '22
Q2 2022 net revenues of $267 million increased 6%, compared to Q2 2021 Q2 2022 net income of $30 million or $0.11 per diluted share, compared to net income of $43 million or $0.15 per diluted share in Q2 2021 Q2 2022 Adjusted EBITDA of $136 million increased 1%, compared to Q2 2021 Q2 2022 Adjusted
20 Jul '22
Names Michael F. Biehl as Interim Chief Financial Officer
CLEVELAND, July 20, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today
19 May '22
CLEVELAND, May 19, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced the departure of Scott Leffler, Sotera Health’s Chief

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.